People with treatment-resistant depression and/or acute suicidal ideation can find relief from their debilitating symptoms at Star Behavioral Health. The health center provides Spravato ketamine for patients that have not found recovery through traditional forms of treatment. Spravato is the intranasal form of ketamine administration, also known as Esketamine.
Star Behavioral Health is led by Dr. Pamela Ruppel, a psychiatric nurse practitioner. With over two decades of experience, Dr. Ruppel has both the expertise and the compassion to help patients overcome their diseases. She and the team at the mental health center approach each patient as an individual for a truly unique and tailored patient experience. By using breakthrough ketamine therapy along with other forms of traditional mental therapy, Dr. Ruppel has helped many people regain control of their health.
Spravato, also known as Esketamine, is taken as a nasal spray and typically prescribed in conjunction with a conventional oral antidepressant, as it may enhance the effect of those drugs.
In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn’t responded to other treatments. A year later, the agency added patients who are having suicidal thoughts or have recently attempted to harm themselves or take their own lives.